| abstract |
Disclosed herein are compositions and methods related to mutant viruses, specifically mutant influenza viruses. The mutant viruses disclosed herein contain a mutant M2 sequence and are useful in immunogenic compositions, eg, as vaccines. Also disclosed herein are methods for propagating viral mutants, compositions and cells therefor, and methods, devices and compositions related to vaccination. |